• Home
  • Search Results

Search Results

Young Adult (18-34)
2349 studies match your search
Coming Soon

Study on the Safety and Effects of AVZO-103 on Tumors

We're testing a new treatment called AVZO-103, alone and with another drug, to find the safest and most effective dose. We want to see if this combination can help treat advanced solid tumors. We're also studying how your body processes and reacts to AVZO-103 to learn who might benefit most from it.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Bladder)
  • Urinary and Bladder
Not currently enrolling

Autism Oral History

We're exploring how adults with autism in North Carolina view themselves and each other. We want to learn if there's a sense of community among them and how their thoughts have evolved.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Opinions and Perceptions
Visit Location
100% Remote (online, phone, text)
Open

Study of Caregivers of Children with Asthma

Have you had trouble getting your child's asthma medication filled at the pharmacy? Have you been inconvenienced because of problems with the prescription, lack of insurance coverage for the drug, or need for a prior authorization? We want to hear from you about the problems you've faced and how we can make getting your child's asthma medication easier and more convenient. We are conducting a research study of caregivers that involves one virtual discussion session with a researcher and other caregivers of children with asthma. You will be compensated for your time.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Allergy
  • Chronic Conditions
  • Minority Health
  • and 4 more
Visit Location
100% Remote (online, phone, text)
Open

Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer

Do you have Stage III or IV Squamous Cell Skin Cancer that is considered high risk? If so,you may be able to take part in a research study evaluating combination therapies versus the standard approach for your type of cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Head and Neck)
Open

Memory for changes in Aging

Are you between the ages of 18 and 35 or 65 and 85? Are you interested in contributing to research that wants to understand how human memory works? If so, you may be able to take part in a study on how younger and older adults learn and remember words. You can help us learn more about how memory works in adults! Compensation provided.

Age & Gender
  • 18 years ~ 85 years
  • Male, Female, Gender Inclusive
Study Interest
  • Aging
  • Healthy Volunteer or General Population
  • Opinions and Perceptions
Open

Social Media and Mood Across the Menstrual Cycle

Do you feel like your mood is affected by your menstrual cycle? Do you feel like your social media use changes depending on your mood? If you experience a regular menstrual cycle, you may be eligible to participate in a research study to better understand the factors that influence mood and social media use across the menstrual cycle. Compensation provided.

Age & Gender
  • 18 years ~ 25 years
  • Female
Study Interest
  • Healthy Volunteer or General Population
  • Mental and Emotional Health
  • Women's Health
  • UNC Students (undergrad, grad, professional)
Visit Location
100% Remote (online, phone, text)
Open

Study on New Gel for Women's Health

Have you been told you have cervical cancer and are getting ready for radiation therapy? You might be able to join a study that tests a special gel called Barrigel during your treatment. This gel could protect your healthy organs from the effects of radiation, making your treatment safer and possibly with fewer side effects. If you join, a doctor will use Barrigel to create space between your cervix and rectum during your cancer treatment. This has been used with prostate cancer patients to keep healthy tissues safe from radiation. Our study wants to see if it works well for people with cervical cancer too.

Age & Gender
  • 18 years ~ 99 years
  • Female
Study Interest
  • Cancer (Cervical)
  • Sexual and/or Reproductive Health
  • Women's Health
Open

Safety of MOON101 for the Treatment of Peanut Allergy

MOON101 is being developed to treat patients who suffer from peanut allergy and to improve the overall safety and efficacy compared to other available treatment routes. Potential advantages of MOON101 include an anticipated lower applied dose of peanut allergen compared to other products. The MOON101 system delivers peanut allergen via a microneedle (MN) stamp. Microneedle technology is similar to a skin prick test (SPT), which is very well tolerated. The consistent dose delivery should enhance efficacy of the stamp and reduce variability in response. Improvement in safety coupled with improved efficacy is the goal of this product.

Age & Gender
  • 4 years ~ 55 years
  • Male, Female, Gender Inclusive
Study Interest
  • Allergy
Coming Soon

P-RAD(+)TN - DCT

You are being asked to take part in this study because you have triple negative (TN) breast cancer that has spread to your lymph nodes. You are also planning to get chemo-immunotherapy treatment before surgery. Radiation therapy (RT) has been shown to improve the body's immune response against tumors when it is given with a drug called pembrolizumab. The purpose of this study is to find the best and safest dose of radiation (low or high) when given with pembrolizumab. Radiation is measured in Gy (pronounced "gray"). You will be randomly assigned (like flipping a coin) to receive either a low dose RT boost (9 Gy) or a high dose RT boost (24 Gy). The RT will be given with one dose of pembrolizumab. This is a hybrid decentralized study where some if not all assessments may be performed close to your home.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Breast)
Open

Stress, queer families, and microbiome

Do you identify as queer? Are you currently family planning? You may be eligible for our study. We are interested in understanding how stress and social support during family planning are related to health outcomes in queer parents and their infants. Study participation will includes interviews, survey completion, and fecal and skin microbiome collection. Compensation provided.

Age & Gender
  • 18 years ~ 99 years
  • Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population
  • Microbiome
  • Pregnancy
  • and 5 more
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research